August 18-21, 2016

Swissotel Chicago
Chicago, IL

Thursday, June 30, 2011

Olympus Biotech- Exhibitor

Olympus Biotech Corporation is dedicated to the further advancement of orthopedics and regenerative medicine to improve the lives of patients around the world.  Olympus Biotech markets and sells OP-1™ Putty and OP-1™ Implant which are currently approved in the U.S. under Humanitarian Device Exemptions (HDEs) for revision posterolateral lumbar spine fusion and for the treatment of long bone
nonunions, respectively.  OP-1 is also approved in Australia and Canada as OP-1 Implant, and in Switzerland and the European Union as Osigraft and Opgenra.  Approximately 40,000 patients have been treated globally with OP-1 Products.

Learn more at

No comments:

Post a Comment